The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009

被引:351
作者
Kreyenbuhl, Julie [1 ,2 ]
Buchanan, Robert W. [3 ]
Dickerson, Faith B. [4 ]
Dixon, Lisa B. [1 ,2 ]
机构
[1] Univ Maryland, Sch Med, Dept Psychiat, Div Res Serv, Baltimore, MD 21201 USA
[2] Mental Illness Res Educ & Clin Ctr, VA Capitol Hlth Care Network VISN 5, Baltimore, MD USA
[3] Univ Maryland, Sch Med, Dept Psychiat, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA
[4] Sheppard Pratt Hlth Syst, Baltimore, MD USA
关键词
evidence-based practices; psychopharmacologic treatments; psychosocial interventions; ANTIPSYCHOTIC-DRUGS; QUALITY; GUIDELINES; CARE;
D O I
10.1093/schbul/sbp130
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The Schizophrenia Patient Outcomes Research Team (PORT) project has played a significant role in the development and dissemination of evidence-based practices for schizophrenia. In contrast to other clinical guidelines, the Schizophrenia PORT Treatment Recommendations, initially published in 1998 and first revised in 2003, are based primarily on empirical data. Over the last 5 years, research on psychopharmacologic and psychosocial treatments for schizophrenia has continued to evolve, warranting an update of the PORT recommendations. In consultation with expert advisors, 2 Evidence Review Groups (ERGs) identified 41 treatment areas for review and conducted electronic literature searches to identify all clinical studies published since the last PORT literature review. The ERGs also reviewed studies preceding 2002 in areas not covered by previous PORT reviews, including smoking cessation, substance abuse, and weight loss. The ERGs reviewed over 600 studies and synthesized the research evidence, producing recommendations for those treatments for which the evidence was sufficiently strong to merit recommendation status. For those treatments lacking empirical support, the ERGs produced parallel summary statements. An Expert Panel consisting of 39 schizophrenia researchers, clinicians, and consumers attended a conference in November 2008 in which consensus was reached on the state of the evidence for each of the treatment areas reviewed. The methods and outcomes of the update process are presented here and resulted in recommendations for 16 psychopharmacologic and 8 psychosocial treatments for schizophrenia. Another 13 psychopharmacologic and 4 psychosocial treatments had insufficient evidence to support a recommendation, representing significant unmet needs in important treatment domains.
引用
收藏
页码:94 / 103
页数:10
相关论文
共 23 条
[1]  
[Anonymous], COCHRANE DATABASE SY
[2]  
[Anonymous], 1998, SCHIZOPHRENIA BULL, V24, P11, DOI DOI 10.1093/OXFORDJOURNALS.SCHBUL.A033303
[3]  
[Anonymous], 2006, PREVENTING CHRONIC D
[4]  
Buchanan R.W., 2009, SCHIZOPHRENIA BULL, V36, P71, DOI DOI 10.1093/SCHBUL/SBP116
[5]   Changes Over Time and Disparities in Schizophrenia Treatment Quality [J].
Busch, Alisa B. ;
Lehman, Anthony F. ;
Goldman, Howard ;
Frank, Richard G. .
MEDICAL CARE, 2009, 47 (02) :199-207
[6]   Guideline recommendations for treatment of schizophrenia -: The impact of managed care [J].
Dickey, B ;
Normand, SLT ;
Hermann, RC ;
Eisen, SV ;
Cortés, DE ;
Cleary, PD ;
Ware, N .
ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (04) :340-348
[7]   The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements [J].
Dixon, Lisa B. ;
Dickerson, Faith ;
Bellack, Alan S. ;
Bennett, Melanie ;
Dickinson, Dwight ;
Goldberg, Richard W. ;
Lehman, Anthony ;
Tenhula, Wendy N. ;
Calmes, Christine ;
Pasillas, Rebecca M. ;
Peer, Jason ;
Kreyenbuhl, Julie .
SCHIZOPHRENIA BULLETIN, 2010, 36 (01) :48-70
[8]   Implementing Evidence-Based Practices for People With Schizophrenia [J].
Drake, Robert E. ;
Bond, Gary R. ;
Essock, Susan M. .
SCHIZOPHRENIA BULLETIN, 2009, 35 (04) :704-713
[9]  
Eccles Martin, 2002, J Health Serv Res Policy, V7, P98, DOI 10.1258/1355819021927746
[10]   Assessing the quality of reports of randomized clinical trials: Is blinding necessary? [J].
Jadad, AR ;
Moore, RA ;
Carroll, D ;
Jenkinson, C ;
Reynolds, DJM ;
Gavaghan, DJ ;
McQuay, HJ .
CONTROLLED CLINICAL TRIALS, 1996, 17 (01) :1-12